No Data
No Data
Gaush Meditech Ltd Schedules Board Meeting for Annual Results and Dividend Consideration
GAUSH MEDITECH (02407.HK) will hold a Board of Directors meeting on March 26 to approve the annual performance.
On March 14, Grains Exchange reported that GAUSH MEDITECH (02407.HK) announced it will hold a Board of Directors meeting on March 26, 2025, to approve the announcement of the annual performance of the company and its subsidiaries for the year ending December 31, 2024, as well as to consider a proposal for the distribution of a final dividend (if any).
Gaush Meditech Unit's Imaging Diagnostic Platform Gets Registration Approval in China
GAUSH MEDITECH: NOTICE OF BOARD MEETING
GAUSH MEDITECH (02407.HK): The ANTERION ophthalmic testing instrument has obtained the medical instruments registration certificate from the National Medical Products Administration.
On March 13, Gelonghui reported that GAUSH MEDITECH (02407.HK) announced that its wholly-owned subsidiary, Peking GAUSH YW Technology Co., Ltd., has obtained a medical instruments registration certificate approved by the National Medical Products Administration of China for an ANTERION ophthalmic testing device (a three-in-one anterior segment multimodal imaging diagnostic platform) produced by its important upstream partner, Heidelberg. The ANTERION ophthalmic testing device is a multimodal imaging diagnostic platform that integrates biometry, corneal topography, and anterior segment OCT, capable of addressing refractive issues, corneal diseases, and glaucoma.
Gaush Meditech Expands Product Portfolio With NMPA Approval for ANTERION